調查批次:CHT2014-07 | 檢體寄出日期:2014-07-21 | 報告回收截止日期:2014-07-28 | 回收份數:21 |
T3 檢驗院際品管調查結果: | ||
2.歷次品管檢體 T3 檢驗值之實驗室間 CV 分佈圖 | ||
4.至本次各單位 z score 分佈圖 | 5.至本次各單位 D% 分佈圖 | 6.至本次各單位 SDI 分佈圖 |
檢驗單位 <代碼> |
確診醫院 <代碼> |
回報 天數 |
檢體 S1 |
檢體 S2 |
||||||||||||
( ng/dL ) |
D |
D% |
z |
SDI |
Da% |
( ng/dL ) |
D |
D% |
z |
SDI |
Da% |
|||||
RH01b | RH01 | 2 |
2 |
5 |
190 |
-17.0 |
-8.2 |
-1.0 |
-0.2 |
-34 |
70 |
-4.0 |
-5.4 |
-0.7 |
0.6 |
-23 |
RH07b | RH07 | 3 |
2 |
3 |
205 |
-2.0 |
-1.0 |
-0.1 |
1.0 |
-4 |
67 |
-7.0 |
-9.5 |
-1.2 |
0.2 |
-40 |
RH14 | RH14 | 7 |
2 |
3 |
200 |
-7.0 |
-3.4 |
-0.4 |
0.6 |
-14 |
57 |
-17.0 |
-23.0 |
-2.9 |
-1.4 |
-96 |
RH15 | RH15 | 7 |
2 |
5 |
188 |
-19.0 |
-9.2 |
-1.1 |
-0.3 |
-38 |
69 |
-5.0 |
-6.8 |
-0.8 |
0.5 |
-28 |
CL009 | CL009 | 4 |
2 |
5 |
181 |
-26.0 |
-12.6 |
-1.6 |
-0.8 |
-52 |
70 |
-4.0 |
-5.4 |
-0.7 |
0.6 |
-23 |
CL010 | CL010 | 4 |
2 |
6 |
264 |
57.0 |
27.5 |
3.4 |
5.4 |
114 |
74 |
0.0 |
0.0 |
0.0 |
1.3 |
0 |
CL012 | CL012 | 7 |
2 |
3 |
187 |
-20.0 |
-9.7 |
-1.2 |
-0.4 |
-40 |
59 |
-15.0 |
-20.3 |
-2.5 |
-1.1 |
-85 |
CL013 | CL013 | 7 |
2 |
5 |
197 |
-10.0 |
-4.8 |
-0.6 |
0.4 |
-20 |
70 |
-4.0 |
-5.4 |
-0.7 |
0.6 |
-23 |
CL014a | CL014 | 7 |
2 |
3 |
187 |
-20.0 |
-9.7 |
-1.2 |
-0.4 |
-40 |
62 |
-12.0 |
-16.2 |
-2.0 |
-0.6 |
-68 |
CL015 | CL015 | 7 |
2 |
5 |
161 |
-46.0 |
-22.2 |
-2.8 |
-2.3 |
-92 |
62 |
-12.0 |
-16.2 |
-2.0 |
-0.6 |
-68 |
Median of RIA Group |
189 |
68 |
||||||||||||||
Range of RIA Group |
161 - 264 |
57 - 74 |
||||||||||||||
Robust mean of RIA Group |
192 ( n = 10 ) |
66 ( n = 10 ) |
||||||||||||||
Robust SD of RIA Group |
13.3 |
6.4 |
||||||||||||||
CV of RIA Group |
6.9% |
9.7% |
||||||||||||||
檢驗單位 <代碼> |
確診醫院 <代碼> |
回報 天數 |
檢體 S1 |
檢體 S2 |
||||||||||||
( ng/dL ) |
D |
D% |
z |
SDI |
Da% |
( ng/dL ) |
D |
D% |
z |
SDI |
Da% |
|||||
RH01a | RH01 | 7 |
4 |
9 |
233 |
26.0 |
12.6 |
1.6 |
1.2 |
52 |
76 |
2.0 |
2.7 |
0.3 |
-0.4 |
11 |
RH02c | RH02 | 7 |
4 |
1 |
214 |
7.0 |
3.4 |
0.4 |
-0.1 |
14 |
80 |
6.0 |
8.1 |
1.0 |
0.0 |
34 |
RH06 | RH06 | 8 |
4 |
9 |
189 |
-18.0 |
-8.7 |
-1.1 |
-1.7 |
-36 |
85 |
11.0 |
14.9 |
1.9 |
0.5 |
62 |
RH07a | RH07 | 1 |
4 |
2 |
201 |
-6.0 |
-2.9 |
-0.4 |
-0.9 |
-12 |
78 |
4.0 |
5.4 |
0.7 |
-0.2 |
23 |
RH12 | RH12 | 3 |
4 |
2 |
222 |
15.0 |
7.2 |
0.9 |
0.5 |
30 |
59 |
-15.0 |
-20.3 |
-2.5 |
-2.0 |
-85 |
RH19 | RH19 | 4 |
4 |
2 |
213 |
6.0 |
2.9 |
0.4 |
-0.1 |
12 |
82 |
8.0 |
10.8 |
1.4 |
0.2 |
45 |
RH20 | RH20 | 7 |
4 |
7 |
247 |
40.0 |
19.3 |
2.4 |
2.1 |
80 |
99 |
25.0 |
33.8 |
4.2 |
1.8 |
141 |
CL005 | CL005 | 3 |
4 |
9 |
202 |
-5.0 |
-2.4 |
-0.3 |
-0.8 |
-10 |
72 |
-2.0 |
-2.7 |
-0.3 |
-0.8 |
-11 |
CL006a | CL006 | 4 |
4 |
1 |
213 |
6.0 |
2.9 |
0.4 |
-0.1 |
12 |
74 |
0.0 |
0.0 |
0.0 |
-0.6 |
0 |
CL008 | CL008 | 7 |
4 |
2 |
216 |
9.0 |
4.3 |
0.5 |
0.1 |
18 |
78 |
4.0 |
5.4 |
0.7 |
-0.2 |
23 |
CL011 | CL011 | 1 |
4 |
13 |
222 |
15.0 |
7.2 |
0.9 |
0.5 |
30 |
94 |
20.0 |
27.0 |
3.4 |
1.4 |
113 |
Median of CLIA Group |
214 |
78 |
||||||||||||||
Range of CLIA Group |
189 - 247 |
59 - 99 |
||||||||||||||
Robust mean of CLIA Group |
215 ( n = 11 ) |
80 ( n = 11 ) |
||||||||||||||
Robust SD of CLIA Group |
15.5 |
10.3 |
||||||||||||||
CV of CLIA Group |
7.2% |
12.9% |
||||||||||||||
Median of All Labs |
202 |
72 |
||||||||||||||
Range of All Labs |
161 - 264 |
57 - 99 |
||||||||||||||
Robust mean of All Labs |
205 ( n = 21 ) |
72 ( n = 21 ) |
||||||||||||||
Robust SD of All Labs |
20.8 |
10.7 |
||||||||||||||
CV of All Labs |
10.1% |
14.9%
|
||||||||||||||
Certified assigned value ( Xa )( ng/dL ) |
207 |
74 |
||||||||||||||
Expanded uncertainty ( Ua ) |
3.3 |
0.7 |
||||||||||||||
Relative expanded uncertainty |
1.6% |
1.0% |
||||||||||||||
Coverage factor k |
2.6 |
2.6 |
||||||||||||||
Effective degrees of freedom veff |
5 |
5 |
||||||||||||||
SD for proficiency assessment ( σp ) |
16.6 |
5.9 |
||||||||||||||
|
Method Code
|
Laboratory |
|
Radioimmunoassay ( Competitive-type ) |
2 |
RH01b, RH07b, RH14, RH15, CL009, CL010, CL012, CL013, CL014a, CL015, |
Chemiluminescent Immunoassay ( Competitive-type ) |
4 |
RH01a, RH02c, RH06, RH07a, RH12, RH19, RH20, CL005, CL006a, CL008, CL011, |
Reagent Code |
Laboratory |
|
Abbott Architect |
1 |
RH02c, CL006a, |
Beckman Coulter Access |
2 |
RH07a, RH12, RH19, CL008, |
Cisbio RIA-gnost |
3 |
RH07b, RH14, CL012, CL014a, |
Immunotech |
5 |
RH01b, RH15, CL009, CL013, CL015, |
MP |
6 |
CL010, |
Siemens ADVIA Centaur |
7 |
RH20, |
Siemens Immulite 2000 |
9 |
RH01a, RH06, CL005, |
Roche |
13 |
CL011, |
若有任何疑問,歡迎來電(函)聯繫或指教
財團法人預防醫學基金會
地 址:10699 台北郵政 26-624 號信箱 電 話:(02)
2703-6080
e-mail:
傳 真: (02)
2703-6070
updated
: 2014-07-30